Patients with Hashimoto’s thyroiditis present higher immune response to COVID-19 mRNA vaccine compared to normal individuals

Author:

Polymeris AntonisORCID,Papapetrou Petros D.,Psachna Stavroula,Ioannidis Dimitrios,Lilis Dimitrios,Drakou Maria,Vaiopoulos Aristeidis,Polymerou Vaia,Spanos Georgios

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Endocrinology, Diabetes and Metabolism

Reference12 articles.

1. Fawcett J, Hutton C, Mc Lachlan SM, Clark F, Rees Smith B (1984) Defective regulation of the immune response to tetanus toxoid in Hashimoto’s disease. Immunology 52:525–528

2. English E, Cook LE, Piec I, Dervisevic S, Fraser WD, John WG (2021) Performance of the abbott SARS-CoV-2 IgG II quantitative antibody assay including the new variants of concern, VOC 202012/V1 (United Kingdom) and VOC 202012/V2 (South Africa), and first steps towards global harmonization of COVID-19 antibody methods. J Clin Microbiol 59(9):e0028821. https://doi.org/10.1128/JCM.00288-21

3. Ferrara P, Gianfredi V, Tomaselli V, Polosa R (2022) The effect of smoking on humoral response to COVID-19 vaccines: a systematic review of epidemiological studies. Vaccines 10(2):303. https://doi.org/10.3390/vaccines10020303

4. Nomura Y, Sawahata M, Nakamura Y, Koike R, Katsube O, Hagiwara K, Niho S, Masuda N, Tanaka T, Sugiyama K (2021) Attenuation of antibody titers from 3 to 6 months after the second dose of the BNT162b2 vaccine depends on sex, with age and smoking risk factors for lower antibody titers at 6 months. Vaccines (Basel) 9(12):1500. https://doi.org/10.3390/vaccines9121500

5. Watanabe M, Balena A, Tuccinardi D, Tozzi R, Risi R, Masi D, Caputi A, Rossetti R, Spoltore ME, Filippi V, Gangitano H, Manfrini S, Mariani S, Lubrano C, Lenzi A, Mastroianni C, Gnessi L (2021) Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID-19 mRNA vaccine. Diabetes Metab Res Rev 38(1):e3465. https://doi.org/10.1002/dmer.3465

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3